Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine.
about
HMG CoA reductase inhibitors (statins) for kidney transplant recipientsInterleukin 2 receptor antagonists for kidney transplant recipientsHMG CoA reductase inhibitors (statins) for kidney transplant recipientsTarget of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipientsProfiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational studySirolimus therapy following early cyclosporine withdrawal in transplant patients: mechanisms of action and clinical results.The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney diseaseMycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection.Late kidney allograft loss: what we know about it, and what we can do about itMycophenolate mofetil in solid-organ transplantation.A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients.Strategies to prevent chronic allograft nephropathy in kidney transplantation: focus on calcineurin inhibitors.Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation.Current and future immunosuppressive strategies in renal transplantation.Immunosuppression: towards a logical approach in liver transplantation.Strategies for minimizing immunosuppression in kidney transplantation.Renal transplantation, immunosuppression and the skin: an update.Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome.Clinical application of sirolimus in renal transplantation: an update.Sirolimus: a new option in transplantation.Efficacy and safety of basiliximab in kidney transplantation.A prospective, multinational pharmacoepidemiological study of clinical conversion to sirolimus immunosuppression after renal transplantation.Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients.Therapeutic targets in the treatment of allograft fibrosis.Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients.Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability.Mycophenolate mofetil and sirolimus combination in renal transplantation.Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipientsCalcineurin inhibitor-free immunosuppression in kidney transplantation.Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result.Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients.mTOR Inhibition: From Aging to Autism and Beyond.Considerations in sirolimus use in the early and late post-transplant periods.Clinical Significance of the Pharmacological Efficacy of Tacrolimus Estimated by the Lymphocyte Immunosuppressant Sensitivity Test (LIST) Before and After Renal Transplantation.Current immunosuppressive treatment after kidney transplantation.Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment.Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation.An evaluation of sirolimus in renal transplantation.Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update.
P2860
Q24200984-5843C2CC-7708-4C3A-A624-5E41465E7F8CQ24240492-E2263FFE-1F50-4065-9543-DA703B281FF1Q24241098-07EACFA1-218B-4681-AAE0-F30237E49B1CQ24246340-DFCCE668-EE21-4754-93E9-BC20945D52F5Q28484885-5379B108-CB83-467A-8F69-D829D1134086Q33376348-926D2335-2175-442E-8BA2-F889714AE129Q34600282-252DDDBE-C9B1-4F26-85D3-A7D173F991B6Q34607590-29CB9857-66B3-40D1-814B-E22E0BF28089Q35153318-EDD83614-8D86-4127-A1CA-00F03422BF7BQ35594016-0597BCF1-5126-468B-B69B-705CD47A4EF4Q35827807-071ABA8D-18CF-4425-9EFB-AE184DAB4DB7Q35841386-E984DE47-4CA1-44F0-9730-C75BD9BF8A3EQ35845541-3BA9DE7C-904E-461E-A512-B08DC3AF1BC7Q35906315-61CE26DD-402B-4C6A-8843-8293FD35B2F5Q35987954-8AF4F016-6131-48AC-B2D5-2D90352E22FCQ35990853-F5979200-B81C-4BFB-9171-D68A34ED92D2Q36000874-AA928F47-11ED-450B-94E6-0389699F4A4CQ36029868-25FABDF0-C991-4783-8FCE-D3ADB1ED5120Q36054093-D383F97E-BFAE-4D6D-BE37-1D103FB2463DQ36082082-E572D494-6583-4295-BE47-E339927A6E02Q36150553-0FF21FB1-4069-4C1E-8584-219028E9E0A1Q36183858-9BEB4C92-F084-49F3-8E50-B94BD439352CQ36379888-2E0037B0-80F3-4288-AD4E-6E3E11381E17Q36447581-22B02FDA-32EF-42FF-B694-9B96E309A56BQ36505748-0005D3F6-68CE-436E-B21F-F40B7704E4D7Q36544988-D5C2B202-FD94-43F0-85D4-37B0424884DCQ36575992-9CB70B44-2792-43B4-BF91-01BFDD692671Q36677625-70F69F64-CB98-43F3-B010-5DCC0352C02DQ36889001-748A0B06-FB7B-4DA3-8BFE-EB57DA1D9116Q37064446-658C5867-CE55-4CAA-9F4C-E31C48E7D781Q37097694-F800E034-77D1-4D7B-A5DC-CF61CB5BF6C1Q37176562-43B93622-E3D6-4289-B155-75792E02FB28Q37385781-E3A7D202-4A70-4440-BD3C-C0F8606F594CQ37517602-6A472DC1-85FF-460A-ABC7-0CC441F68A58Q37541921-8F4B1B93-F9AD-4AD3-AD26-ECD9A758422FQ37834028-CE070BB1-0FA9-4D8D-8587-90830A6FBC96Q37873950-449BD14F-5F3D-4B92-9BEE-743365C99F75Q37939057-384449BD-F000-4D84-8D3E-5AE790D9C757Q38038696-87B83E4A-A56C-447C-88A0-6F4A02A9FB63Q38059865-E73C7814-CBEA-4CBE-ACC8-7FFD81D94423
P2860
Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Kidney transplantation without ...... sirolimus versus cyclosporine.
@en
Kidney transplantation without ...... sirolimus versus cyclosporine.
@nl
type
label
Kidney transplantation without ...... sirolimus versus cyclosporine.
@en
Kidney transplantation without ...... sirolimus versus cyclosporine.
@nl
prefLabel
Kidney transplantation without ...... sirolimus versus cyclosporine.
@en
Kidney transplantation without ...... sirolimus versus cyclosporine.
@nl
P2093
P1433
P1476
Kidney transplantation without ...... sirolimus versus cyclosporine.
@en
P2093
Andrew C Novick
Barbara Mastroianni
Charles Modlin
Daniel J Cook
David Goldfarb
Jingyuan Feng
Kathy Savas
Stuart M Flechner
Venkatesh Krishnamurthi
P304
P356
10.1097/00007890-200210270-00002
P577
2002-10-01T00:00:00Z